Evidence map›Paper›PMID 18325350›Full record

ArticleBiochimica et biophysica acta2008

Zinc mesoporphyrin induces rapid and marked degradation of the transcription factor Bach1 and up-regulates HO-1.

Weihong Hou, Ying Shan, Jianyu Zheng, Richard W Lambrecht, Susan E Donohue, Herbert L Bonkovsky

Open access · greenAbstract read
In one paragraph

Article in Biochimica et biophysica acta, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Update on heme biosynthesis, tissue-specific regulation, heme transport, relation to iron metabolism and cellular energy.Liver international : official journal of the International Association for the Study of the Liver · 2024
    Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Metalloporphyrins - an update.Frontiers in pharmacology · 2012
    Article
  14. Heme and HO-1 Inhibition of HCV, HBV, and HIV.Frontiers in pharmacology · 2012
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Weihong HouThe Liver-Biliary-Pancreatic Center, Carolinas Medical Center, Charlotte, NC 28232-2861, USA.
Ying Shan
Jianyu Zheng
Richard W Lambrecht
Susan E Donohue
Herbert L Bonkovsky
UConn Health · USUniversity of North Carolina at Charlotte · USCarolinas Medical Center · USUniversity of Massachusetts Chan Medical School · US

Funding

ZONISAMIDE VERSUS PLACEBOM01RR006192 · NCRR · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI KRANZLER, HENRY RICHARD · 1994 to 2008
$22.1M
REGULATION OF HEPATIC HEME METABOLISMR01DK038825 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BONKOVSKY, HERBERT L · 1987 to 2009
$3.4M
Research Network for Drug-Induced Liver DiseaseU01DK065193 · NIDDK · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI PROTIVA, PETR · 2003 to 2007
$1.2M
HEPATITIS C CLINICAL TRIAL-CLINICAL CENTERSN01DK092326 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BONKOVSKY, HERBERT L · 1999 to 2000
$872k
NCRR NIH HHS M01 RR006192NIDDK NIH HHS N0-1 DK92326NIDDK NIH HHS R01 DK038825NIDDK NIH HHS R01-DK38825NIDDK NIH HHS U0-1 DK065193NIDDK NIH HHS U01 DK065193NLM NIH HHS N01 DK092326
6 · The paper itself

Abstract

Heme oxygenase 1 (HO-1) is the first and rate-controlling enzyme in heme degradation. Bach1 is a mammalian transcriptional repressor of HO-1. To understand how zinc mesoporphyrin (ZnMP) induces the expression of HO-1, we investigated the effects of ZnMP on Bach1 mRNA and protein levels in human hepatoma Huh-7 cells by quantitative RT-PCR and Western blots. We found that ZnMP markedly up-regulated HO-1 mRNA and protein levels, and rapidly and significantly decreased Bach1 protein levels by increasing degradation of Bach1 protein [half life (t(1/2)) from 19 h to 45 min], whereas ZnMP did not influence Bach1 mRNA levels. The proteasome inhibitors, epoxomicin and MG132, significantly inhibited degradation of Bach1 by ZnMP in a dose-dependent fashion, indicating that the degradation of Bach1 by ZnMP is proteasome-dependent. Purified Bach1 C-terminal fragment bound heme, but there was no evidence for binding of ZnMP to the heme-binding region of Bach1. In conclusion, ZnMP produces profound post-transcriptional down-regulation of Bach1 protein levels and transcriptional up-regulation of HO-1. Our results indicate that ZnMP up-regulates HO-1 gene expression by markedly increasing Bach1 protein degradation in a proteasome-dependent manner.

Indexed as

Basic-Leucine Zipper Transcription FactorsCell Line, TumorFanconi Anemia Complementation Group ProteinsGene Expression Regulation, EnzymologicHemeHeme Oxygenase-1HumansLeupeptinsMetalloporphyrinsOligopeptidesProtein BindingRecombinant ProteinsRNA, MessengerUp-RegulationBACH1 protein, humanBasic-Leucine Zipper Transcription Factorsbenzyloxycarbonylleucyl-leucyl-leucine aldehydeepoxomicinFanconi Anemia Complementation Group ProteinsHemeHeme Oxygenase-1LeupeptinsMetalloporphyrinsOligopeptidesRecombinant ProteinsRNA, Messengerzinc mesoporphyrin

Identifiers

PMID18325350
PMCPMC2346609
OpenAlexW2069432963

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.